GPAT Total Liab vs Total Stockholder Equity Analysis

GPAT Stock

10.08 0.01 0.1%

GP Act financial indicator trend analysis is much more than just examining GP Act III latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether GP Act III is a good investment. Please check the relationship between GP Act Total Liab and its Total Stockholder Equity accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GP Act III Acquisition. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Liab vs Total Stockholder Equity

Total Liab vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of GP Act III Total Liab account and Total Stockholder Equity. At this time, the significance of the direction appears to have pay attention.

The correlation between GP Act's Total Liab and Total Stockholder Equity is -0.9. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of GP Act III Acquisition, assuming nothing else is changed. The correlation between historical values of GP Act's Total Liab and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of GP Act III Acquisition are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Total Liab i.e., GP Act's Total Liab and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.9

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from GP Act's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into GP Act III current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GP Act III Acquisition. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Selling General Administrative is likely to gain to about 18 K in 2024, whereas Enterprise Value Over EBITDA is likely to drop (21.1 K) in 2024.

GP Act fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Short Term Debt	Common Stock	Cash	Cash And Short Term Investments	Other Current Assets	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital
Total Assets		0.81	0.86	1.0	-0.87	0.81	-0.86	1.0	1.0	-0.28	0.23	1.0	0.81	-0.28	-0.26	-0.26	0.28	0.24	0.24	-0.28	-0.28	0.25
Short Long Term Debt Total	0.81		0.98	0.85	-0.98	1.0	-0.98	0.81	0.81	-0.61	0.74	0.85	1.0	-0.61	-0.71	-0.71	0.56	0.73	0.73	-0.6	-0.61	0.72
Other Current Liab	0.86	0.98		0.9	-0.96	0.98	-0.95	0.86	0.86	-0.45	0.62	0.9	0.98	-0.46	-0.57	-0.57	0.41	0.6	0.6	-0.45	-0.45	0.58
Total Current Liabilities	1.0	0.85	0.9		-0.9	0.85	-0.89	1.0	1.0	-0.32	0.29	1.0	0.85	-0.33	-0.31	-0.31	0.31	0.3	0.3	-0.32	-0.32	0.31
Total Stockholder Equity	-0.87	-0.98	-0.96	-0.9		-0.98	1.0	-0.86	-0.86	0.65	-0.68	-0.9	-0.98	0.66	0.69	0.69	-0.62	-0.69	-0.69	0.64	0.65	-0.7
Net Debt	0.81	1.0	0.98	0.85	-0.98		-0.98	0.81	0.81	-0.61	0.74	0.85	1.0	-0.61	-0.71	-0.71	0.56	0.73	0.73	-0.6	-0.61	0.72
Retained Earnings	-0.86	-0.98	-0.95	-0.89	1.0	-0.98		-0.86	-0.86	0.68	-0.69	-0.89	-0.98	0.69	0.71	0.71	-0.66	-0.71	-0.71	0.68	0.68	-0.71
Non Current Assets Total	1.0	0.81	0.86	1.0	-0.86	0.81	-0.86		1.0	-0.27	0.22	1.0	0.81	-0.28	-0.26	-0.26	0.28	0.24	0.24	-0.27	-0.27	0.25
Non Currrent Assets Other	1.0	0.81	0.86	1.0	-0.86	0.81	-0.86	1.0		-0.27	0.22	1.0	0.81	-0.28	-0.26	-0.26	0.28	0.24	0.24	-0.27	-0.27	0.25
Common Stock Shares Outstanding	-0.28	-0.61	-0.45	-0.32	0.65	-0.61	0.68	-0.27	-0.27		-0.85	-0.32	-0.61	1.0	0.95	0.95	-1.0	-0.9	-0.9	1.0	1.0	-0.93
Other Stockholder Equity	0.23	0.74	0.62	0.29	-0.68	0.74	-0.69	0.22	0.22	-0.85		0.29	0.74	-0.85	-0.97	-0.97	0.8	1.0	0.99	-0.84	-0.85	0.98
Total Liab	1.0	0.85	0.9	1.0	-0.9	0.85	-0.89	1.0	1.0	-0.32	0.29		0.85	-0.33	-0.31	-0.31	0.31	0.3	0.3	-0.32	-0.32	0.31
Short Term Debt	0.81	1.0	0.98	0.85	-0.98	1.0	-0.98	0.81	0.81	-0.61	0.74	0.85		-0.61	-0.71	-0.71	0.56	0.73	0.73	-0.6	-0.61	0.72
Common Stock	-0.28	-0.61	-0.46	-0.33	0.66	-0.61	0.69	-0.28	-0.28	1.0	-0.85	-0.33	-0.61		0.95	0.95	-1.0	-0.9	-0.91	1.0	1.0	-0.93
Cash	-0.26	-0.71	-0.57	-0.31	0.69	-0.71	0.71	-0.26	-0.26	0.95	-0.97	-0.31	-0.71	0.95		1.0	-0.91	-0.99	-0.99	0.94	0.95	-1.0
Cash And Short Term Investments	-0.26	-0.71	-0.57	-0.31	0.69	-0.71	0.71	-0.26	-0.26	0.95	-0.97	-0.31	-0.71	0.95	1.0		-0.91	-0.99	-0.99	0.94	0.95	-1.0
Other Current Assets	0.28	0.56	0.41	0.31	-0.62	0.56	-0.66	0.28	0.28	-1.0	0.8	0.31	0.56	-1.0	-0.91	-0.91		0.85	0.86	-1.0	-1.0	0.89
Net Invested Capital	0.24	0.73	0.6	0.3	-0.69	0.73	-0.71	0.24	0.24	-0.9	1.0	0.3	0.73	-0.9	-0.99	-0.99	0.85		1.0	-0.89	-0.9	1.0
Short Long Term Debt	0.24	0.73	0.6	0.3	-0.69	0.73	-0.71	0.24	0.24	-0.9	0.99	0.3	0.73	-0.91	-0.99	-0.99	0.86	1.0		-0.9	-0.9	1.0
Total Current Assets	-0.28	-0.6	-0.45	-0.32	0.64	-0.6	0.68	-0.27	-0.27	1.0	-0.84	-0.32	-0.6	1.0	0.94	0.94	-1.0	-0.89	-0.9		1.0	-0.92
Capital Stock	-0.28	-0.61	-0.45	-0.32	0.65	-0.61	0.68	-0.27	-0.27	1.0	-0.85	-0.32	-0.61	1.0	0.95	0.95	-1.0	-0.9	-0.9	1.0		-0.93
Net Working Capital	0.25	0.72	0.58	0.31	-0.7	0.72	-0.71	0.25	0.25	-0.93	0.98	0.31	0.72	-0.93	-1.0	-1.0	0.89	1.0	1.0	-0.92	-0.93

Click cells to compare fundamentals

GP Act Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for GPAT Stock Analysis

When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GPAT Total Liab vs Total Stockholder Equity Analysis

Total Liab vs Total Stockholder Equity

Total Liab vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Total Liab

Total Stockholder Equity

GP Act fundamental ratios Correlations

GP Act Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for GPAT Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Non Currrent Assets Other	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Net Debt	+ 1.0	Short Long Term Debt Total
Short Term Debt	+ 1.0	Short Long Term Debt Total

Capital Stock	- 1.0	Other Current Assets
Total Current Assets	- 1.0	Other Current Assets
Net Working Capital	- 1.0	Cash And Short Term Investments
Net Working Capital	- 1.0	Cash
Other Current Assets	- 1.0	Common Stock
Other Current Assets	- 1.0	Common Stock Shares Outstanding